Lamivudine and high-dose interferon alpha 2a combination treatment in naïve HBeAg-positive immunoactive chronic hepatitis B in children: An East Mediterranean center's experience

European Journal of Pediatrics

Volumn 166, Issue 3, 2007, Pages 195-199

  Yilmaz, Aygen ^a   Akcam, Mustafa ^a   Gelen, Tekinalp ^a   Artan, Reha ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Children; Chronic hepatitis B; Immunoactive; Interferon alpha; Lamivudine; Na ve

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA2A INTERFERON; HEPATITIS B(E) ANTIGEN; LAMIVUDINE;

ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANOREXIA; ARTHRALGIA; ARTICLE; CHEMOTHERAPY INDUCED EMESIS; CHILD; CHILDHOOD DISEASE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DRUG MEGADOSE; FEMALE; FLU LIKE SYNDROME; FOLLOW UP; HAIR LOSS; HEPATITIS B; HUMAN; IMMUNOREACTIVITY; MALE; MONOTHERAPY; NAUSEA; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROCONVERSION; SIDE EFFECT; TREATMENT RESPONSE; WEIGHT REDUCTION;

ADOLESCENT; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS B; HEPATITIS B E ANTIGENS; HUMANS; INTERFERON ALFA-2A; LAMIVUDINE; MALE; REVERSE TRANSCRIPTASE INHIBITORS; TREATMENT OUTCOME; TURKEY;

EID: 33847672703     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-006-0220-2     Document Type: Article

References (21)

1. de Franchis R, Hadengue A, Lau G, Lavanchy D, Lok A, McIntyre N, Mele A, Paumgartner G, Pietrangelo A, Rodes J, Rosenberg W, Valla D (2003) EASL International Consensus Conference on Hepatitis B, Geneva, Switzerland, 13-14 September, 2002. Consensus statement (long version). J Hepatol 39(Suppl 1):S3-S25
2. Dienstag JL, Schiff ER, Wright TL, Perrillo RP, Hann HW, Goodman Z, Crowther L, Condreay LD, Woessner M, Rubin M, Brown NA (1999) Lamivudine as initial treatment for chronic hepatitis B in the United States. N Engl J Med 341(17):1256-1263
3. Dikici B, Ozgenc F, Kalayci AG, Targan S, Ozkan T, Selimoglu A, Doganci T, Kansu A, Tosun S, Arslan N, Kasirga E, Bosnak M, Haspolat K, Buyukgebiz B, Aydogdu S, Girgin N, Yagci RV (2004) Current therapeutic approaches in childhood chronic hepatitis B infection: a multicenter study. J Gastroenterol Hepatol 19(2):127-133
4. Dikici B, Bosnak M, Bosnak V, Dagli A, Ece A, Yagci RV, Haspolat K (2002) Combination therapy for children with chronic hepatitis B virus infection. J Gastroenterol Hepatol 17(10):1087-1091
5. Doo E, Hoofnagle JH (2000) Combination therapy of hepatitis B. Gut 46(4):450-451
6. Gurakan F, Kocak N, Ozen H, Yuce A (2000) Comparison of standard and high dosage recombinant interferon alpha 2b for treatment of children with chronic hepatitis B infection. Pediatr Infect Dis J 19(1):52-56
7. Jarvis B, Faulds D (1999) Lamivudine: a review of its therapeutic potential in chronic hepatitis B. Drugs 58(1):101-141
8. Kocak N, Ozen H, Saltik IN, Gurakan F, Yuce A (2000) Lamivudine for children with chronic hepatitis B. Am J Gastroenterol 95(10):2989-2990
9. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J (1981) Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1(5):431-435
10. Lai CL, Lin HJ, Lau JN, Flok AS, Wu PC, Chung HT, Wong LK, Leung MP, Yeung CY (1991) Effect of recombinant alpha 2 interferon with or without prednisone in Chinese HBsAg carrier children. Q J Med 78(286):155-163
11. Lau GK, Piratvisuth T, Luo KX, Marcellin P, Thongsawat S, Cooksley G, Gane E, Fried MW, Chow WC, Paik SW, Chang WY, Berg T, Flisiak R, McCloud P, Pluck N (2005) Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B. N Engl J Med 352(26):2682-2695
12. Lok AS, McMahon BJ; Practice Guidelines Committee, American Association for the Study of Liver Diseases (AASLD) (2004) Chronic hepatitis B: update of recommendations. Hepatology 39 (3):857-861
13. Marinos G, Naoumov NV, Williams R (1996) Impact of complete inhibition of viral replication on the cellular immune response in chronic hepatitis B virus infection. Hepatology 24 (5):991-995
14. Mutimer D, Dowling D, Cane P, Ratcliffe D, Tang H, O'Donnell K, Shaw J, Elias E, Pillay D (2000) Additive antiviral effects of lamivudine and alpha-interferon in chronic hepatitis B infection. Antivir Ther 5(4):273-277
15. Papatheodoridis GV, Hadziyannis SJ (2004) Review article: current management of chronic hepatitis B. Aliment Pharmacol Ther 19(1):25-37
16. Saltik-Temizel IN, Kocak N, Demir H (2005) Lamivudine and high-dose interferon-alpha combination therapy for naive children with chronic hepatitis B infection. J Clin Gastroenterol 39(1):68-70
17. Schalm SW, Heathcote J, Cianciara J, Farrell G, Sherman M, Willems B, Dhillon A, Moorat A, Barber J, Gray DF (2000) Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial. Gut 46(4):562-568
18. Selimoglu MA, Aydogdu S, Unal F, Zeytinoglu A, Yuce G, Yagci RV (2002) Alpha interferon and lamivudine combination therapy for chronic hepatitis B in children. Pediatr Int 44(4):404-408
19. Sokal EM, Kelly DA, Mizerski J, Badia IB, Areias JA, Schwarz KB, Vegnente A, Little NR, Gardener SD, Jonas MM (2006) Long-term lamivudine therapy for children with HBeAg-positive chronic hepatitis B. Hepatology 43(2):225-232
20. Sokal EM, Conjeevaram HS, Roberts EA, Alvarez F, Bern EM, Goyens P, Rosenthal P, Lachaux A, Shelton M, Sarles J, Hoofnagle J (1998) Interferon alpha therapy for chronic hepatitis B in children: a multinational randomized controlled trial. Gastroenterology 114(5):988-995
21. Tassopoulos NC, Volpes R, Pastore G, Heathcote J, Buti M, Goldin RD, Hawley S, Barber J, Condreay L, Gray DF (1999) Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group. Hepatology 29(3):889-896